Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC), as an independent subset of RCC in the 2016 WHO classification [1], is characterized with poor prognosis of patients caused by high expression of transcript factor E3 (TFE3) fusion gene. Here, TFE3 is linked to MIT family translocation renal cell carcinoma.